KRAS and pancreatic neoplasm: The tumour indications with the most frequent over-editing were ovarian cancer, melanoma and breast cancer showing a prevalence comparable to frequent neoantigen epitopes like KRAS G12D which is present in 33% of all pancreatic cancer patients39,40.